Advertisement
Demo

Roche's lung cancer combo treatment wins FDA approval

Dec 07, 2018 , Reuters
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.


Read the full story...


Trending healthcare news keywords at this moment

healthcare medicare patients study finds data cancer disease kids mental heart drug fda state research flu measles higher care teen risk big launches shows tech depression tied surgery tip